Cepsa Tower, the company's new corporate headquarters that houses almost 2,000 people, is Spain's second tallest building and represents the materialization of Cepsa's growth and internationalization strategy of in recent years, following the entry of International Petroleum Investment Company (IPIC), as sole shareholder.
The headquarters, designed by the architect Norman Foster, reflects the transformation of Cepsa's business model to focus on an increasingly international market. Its height, at 248 metres, provides a unique view of Madrid from its upper floors, taking in some of the city's most emblematic locations such as the Paseo de la Castellana, the Parque del Retiro and the Santiago Bernabéu stadium.
Cepsa today operates an integrated business model spanning the entire hydrocarbon value chain. This integration allows the company to act with greater flexibility and the ability to respond quickly as a business.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7703451-cepsa-new-headquarters-new-company/
The S90 marks a giant step forward for Volvo Cars. The Swedish car maker is better known for its SUVs and estates, but with the launch of the S90 Volvo is clearly intent on shaking up the premium sedan segment with its distinctive executive class sedan.
Equipped with a host of new technologies ranging from cutting edge safety to cloud-based apps and services, the S90 is further proof of the Swedish brand’s continuing transformation.
“With the launch of the XC90 we made a clear statement of intent. We are now clearly and firmly in the game. With $11 USD billion of investment over the past five years we have not only reimagined what Volvo Cars can be – we are now delivering on our promise of a resurgent and relevant Volvo Cars brand,” said Håkan Samuelsson, President & CEO, Volvo Car Group.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7702651-volvo-stakes-its-claim-with-the-S90/
World trade in perishable foods turns a page as Maersk Container Industry (MCI), an independent business unit in the Maersk Group conglomerate, today announced that it has begun production of the first refrigerated containers and Star Cool refrigeration machines built in South America at its new MCI facility in San Antonio, Chile.
The first trial production of these ISO standard 40 feet reefer containers were successfully delivered during the third quarter of 2015 into the Maersk Line and CMA CGM operations. Shortly thereafter, both shipping lines placed new orders. To further leverage this new value proposition, Maersk Line has secured a fixed monthly volume from the MCI facility allowing for increased agility and fast response time to the demand in the region.
“In this sweet spot of fruit exporters, we have placed the factory right where the demand is. For the first time ever in South America, reefer containers can go straight “from factory to farm”,” said Stig Hoffmeyer, Chief Executive Officer of MCI. “Offering the Star Cool Integrated reefers locally to shipping lines, farmers, fruit distributors and leasing companies, will have a financial benefit counted in thousands of dollars per reefer, and millions for the industry in total,” he continued.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7688551-maersk-container-industry-factory-chile/
The Swiss watch world is about to be joined by an exciting new addition with a venerable name. Czapek, a watch brand that achieved considerable success in the nineteenth century, has been revived and is launching with a distinctive timepiece and an innovative sharing strategy to attract watch lovers.
Czapek & Cie was re-established by three entrepreneurs with a passion for fine watches and outstanding mechanics. The original founder, François Czapek was a Czech-born, Polish watchmaker, who arrived in Geneva, Switzerland, in 1832. In 1839 he founded Patek, Czapek & Cie with fellow pole Antoni Patek. For six years they produced exceptional watches.
At the end of their partnership, in 1845, he founded Czapek & Cie and became Purveyor to the French Emperor Napoleon the Third. At its height, the company had boutiques in Geneva, Warsaw and Paris, Place Vendôme.
“Czapek deserves to be revived, he was one of the great watchmakers of the nineteenth century, who brilliantly combined precision mechanics with extremely refined aesthetics”, says Xavier de Roquemaurel, spokesman for the team. Czapek’s timepieces, which are still coveted at auctions, reveal a quest for beauty through a poetic display of time.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7684451-czapek-cie-19th-century-swiss-watch/
The 1-year Full-Time MBA is the School’s flagship program with just about 100 MBA students. It is a challenging life time experience to learn the art of management and grow personally and professionally.
Full-Time MBA structure is organized around three cornerstones: Planning and Innovating, Controlling and Investing, Leading People and Processes. These core courses represent the competence requirements of a global manager.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7674251-sda-bocconi-1-year-full-time-mba/
ARTIST: The Beat Corporation TITLE: Slaving ForThe System RELEASE: 11/12/2015 LABEL: Supersonic Media (c) 2015 Supersonic Media Ltd The
Beat Corporation are Manchester duo Jody Spence and Tyler Daly. They
came together to create music with no limitations and to share a common
goal, to make music with no boundaries. 2014 saw The Beat Corporation
have releases on legendary dance label Champion Records (Robin S,
Faithless) and they have now teamed up with Supersonic Media to present
their “Slaving For The System” EP. http://www.supersonic-medie.co.uk
ARTIST: Mike Elrington TITLE: Build You Up (To Cut You Down) PRE-ORDER/BUY: http://smarturl.it/BuildyouUp RELEASED: 29/03/2015 LABEL: Supersonic Media
(C) 2015 Supersonic Media
Blistering guitar playing that would make Clapton proud” stats Forte Magazine. “One of the most exciting acts to come out of Australia in many years!” raves Blues Revue Magazine.
http://www.supersonic-medie.co.uk
Last Tuesday night, Laetitia Casta and La Maison Cointreau announced the launch of the Cointreau Creative Crew in the Pompadour Ballroom at the Hotel Café Royal in London. A worldwide philanthropist programme curated by Creative Director Laetitia Casta, the Cointreau Creative Crew aims to develop women’s freedom and encourage them to make their dreams a reality. Launching for the first time in the UK, this programme will culminate in one entrepreneur being awarded a £20,000 bursary to support their creative project which will be announced in Spring 2016.
Decorated with Cointreau elegantly dressed in soft furnishings and floral arrangements, the Pompadour Ballroom played host to 150 guests on the night. The former French model looked stunning and was joined on the night by a host of A-list celebrities including Ella Eyre, Donna Air, Charlie XCX and Laetitia Casta. Additional guests in attendance included CEO of Rémy Cointreau Valérie Chapoulaud-Floquet, established fashion philanthropist Nick Ede, Managing Director of Liberty of London Ed Burstell and Editor of Glamour UK Jo Elvin.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7677251-laetitia-casta-cointreau-creative-crew/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
